Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Consulting agrmnt
Director departure
Appointed director
CC transcript
Notes underwriting agrmnt
Inv. presentation
|
|
Sarepta Therapeutics, Inc. (SRPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| SANDS CAPITAL MANAGEMENT, LLC reports a 2.5% stake in Sarepta Therapeutics, Inc. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.2% stake in Sarepta Therapeutics Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.5% stake in Sarepta Therapeutics Inc. |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/10/2021 |
SC 13G/A
| Capital Research Global Investors reports a 4.8% stake in Sarepta Therapeutics, Inc. |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 11.2% stake in SAREPTA THERAPEUTICS INC |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Tourbillon Capital Partners, L.P. reports a 3.1% stake in Sarepta Therapeutics, Inc. |
| 02/12/2018 |
SC 13G/A
| VANGUARD GROUP INC reports a 7.9% stake in Sarepta Therapeutics Inc |
| 02/12/2018 |
SC 13G/A
| FMR LLC reports a 12% stake in SAREPTA THERAPEUTICS INC |
| 02/09/2018 |
SC 13G/A
| SUSQUEHANNA SECURITIES reports a 5.6% stake in Sarepta Therapeutics, Inc. |
| 01/23/2018 |
SC 13G/A
| BlackRock Inc. reports a 9.7% stake in SAREPTA THERAPEUTICS INC |
| 02/14/2017 |
SC 13G/A
| Sarepta Therapeutics, Inc. reports a 5.7% stake in Sarepta Therapeutics, Inc. |
| 02/14/2017 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 3.5% stake in SAREPTA THERAPEUTICS, INC. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/26/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/10/2017 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 3.8% stake in Sarepta Therapeutics, Inc. |
| 02/10/2016 |
SC 13G/A
| AVI BIOPHARMA INC reports a 6.3% stake in Sarepta Therapeutics Inc |
| 02/13/2012 |
SC 13G/A
| AVI BIOPHARMA INC reports a 3.8% stake in AVI BIOPHARMA, INC. |
| 02/13/2012 |
SC 13G/A
| AVI BIOPHARMA INC reports a 6.3% stake in AVI BIOPHARMA INC |
|
|
|